Alimera Sciences: Deal Closing After All, CVR Still Attractive [Seeking Alpha]
Alimera Sciences, Inc. (ALIM)
Last alimera sciences, inc. earnings: 4/29 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alimerasciences.com/investor-relations
Company Research
Source: Seeking Alpha
Follow Summary Alimera Sciences, Inc. is being acquired by ANI Pharmaceuticals for $5.50 per share, with a contingent value right, or CVR, potentially adding up to $0.50 per share. Despite initial delays and Alimera suing ANI to close the deal, ANI remains committed, expecting to resolve closing conditions promptly. The deal is highly synergistic, adding durable assets to ANI's portfolio, with significant revenue growth and accretion expected by 2025. At $5.54 per share, Alimera Sciences stock is attractive, offering potential CVR payouts based on achievable sales targets, making it a compelling investment. Solskin Alimera Sciences, Inc. NASDAQ: ALIM ) is being acquired for $5.50 per share by ANI Pharmaceuticals ( ANIP ). This is a ~$430 million deal, which is large given the acquirer's $1.16 billion market cap. The deal also includes a contingent value right that is ultimately either worth $0 per share, $0.25 per share or $0.50 per share depending on whether certain po
Show less
Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALIM alerts
High impacting Alimera Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
ALIM
News
- ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven? [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of MergerBusiness Wire
- ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
ALIM
Earnings
- 8/6/24 - Miss
ALIM
Sec Filings
- 9/18/24 - Form SC
- 9/18/24 - Form 4
- 9/16/24 - Form 4
- ALIM's page on the SEC website